logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Walker, Mel, Dr
    Born in May 1974
    Individual (2 offsprings)
    Officer
    icon of calendar 2020-10-14 ~ now
    OF - Director → CIF 0
    Dr Mel Walker
    Born in May 1974
    Individual (2 offsprings)
    Person with significant control
    icon of calendar 2020-10-14 ~ now
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

BIOPHARMA FUTURES LTD

Standard Industrial Classification
70229 - Management Consultancy Activities Other Than Financial Management
Brief company account
Property, Plant & Equipment
47,098 GBP2024-10-31
61,467 GBP2023-10-31
Fixed Assets - Investments
4 GBP2024-10-31
Fixed Assets
47,102 GBP2024-10-31
61,467 GBP2023-10-31
Debtors
Current
40,371 GBP2024-10-31
43,825 GBP2023-10-31
Cash at bank and in hand
512,330 GBP2024-10-31
365,094 GBP2023-10-31
Current Assets
552,701 GBP2024-10-31
408,919 GBP2023-10-31
Creditors
Current, Amounts falling due within one year
-153,705 GBP2023-10-31
Net Current Assets/Liabilities
352,457 GBP2024-10-31
255,214 GBP2023-10-31
Net Assets/Liabilities
399,559 GBP2024-10-31
316,681 GBP2023-10-31
Equity
Called up share capital
100 GBP2024-10-31
100 GBP2023-10-31
Retained earnings (accumulated losses)
399,459 GBP2024-10-31
316,581 GBP2023-10-31
Equity
399,559 GBP2024-10-31
316,681 GBP2023-10-31
Average Number of Employees
12023-11-01 ~ 2024-10-31
12022-11-01 ~ 2023-10-31
Property, Plant & Equipment - Gross Cost
Furniture and fittings
1,571 GBP2024-10-31
499 GBP2023-10-31
Office equipment
2,548 GBP2024-10-31
1,549 GBP2023-10-31
Motor vehicles
107,810 GBP2024-10-31
107,810 GBP2023-10-31
Property, Plant & Equipment - Gross Cost
111,929 GBP2024-10-31
109,858 GBP2023-10-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Furniture and fittings
856 GBP2024-10-31
333 GBP2023-10-31
Office equipment
1,366 GBP2024-10-31
516 GBP2023-10-31
Motor vehicles
62,609 GBP2024-10-31
47,542 GBP2023-10-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
64,831 GBP2024-10-31
48,391 GBP2023-10-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Furniture and fittings
523 GBP2023-11-01 ~ 2024-10-31
Office equipment
850 GBP2023-11-01 ~ 2024-10-31
Motor vehicles
15,067 GBP2023-11-01 ~ 2024-10-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
16,440 GBP2023-11-01 ~ 2024-10-31
Property, Plant & Equipment
Furniture and fittings
715 GBP2024-10-31
166 GBP2023-10-31
Office equipment
1,182 GBP2024-10-31
1,033 GBP2023-10-31
Motor vehicles
45,201 GBP2024-10-31
60,268 GBP2023-10-31
Par Value of Share
Class 1 ordinary share
12023-11-01 ~ 2024-10-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2024-10-31
100 shares2023-10-31

Related profiles found in government register
  • BIOPHARMA FUTURES LTD
    Info
    Registered number 12948994
    icon of addressSuite 1b1, Argyle House Northside, Joel Street, Northwood Hills HA6 1NW
    PRIVATE LIMITED COMPANY incorporated on 2020-10-14 (5 years 2 months). The company status is Active.
    The last date of confirmation statement was made at 2024-10-04
    CIF 0
  • BIOPHARMA FUTURES LTD
    S
    Registered number 12948994
    icon of addressSuite 1b1, Joel Street, Argyle House Northside, Northwood, Middlesex, United Kingdom, HA6 1NW
    CIF 1
  • BIOPHARMA FUTURES LTD
    S
    Registered number 12948994
    icon of addressSuite 1b1, Joel Street, Argyle House Northside, Northwood, United Kingdom, HA6 1NW
    Limited Company in Companies House, United Kingdom
    CIF 2
child relation
Offspring entities and appointments
Active 1
  • icon of address71-75 Shelton Street, Covent Garden, London, United Kingdom
    Active Corporate (3 parents, 1 offspring)
    Equity (Company account)
    7,391 GBP2025-03-31
    Officer
    icon of calendar 2022-10-27 ~ now
    CIF 1 - Director → ME
    Person with significant control
    icon of calendar 2022-10-27 ~ now
    CIF 2 - Ownership of voting rights - More than 25% but not more than 50%OE
    CIF 2 - Ownership of shares – More than 25% but not more than 50%OE

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.